Kaserta is a stealth-mode biotechnology startup developing next-generation antimicrobial therapies for multidrug-resistant infections, with an initial focus on diabetic foot infections. We are building technologies to improve how these therapies are developed, deployed, and scaled to address one of healthcare’s most urgent challenges.
| Website | http://www.kaserta.com |
| Employees | 1 (1 on RocketReach) |
| Founded | 2025 |
| Industry | Biotechnology Research |
Looking for a particular APK Phageomics employee's phone or email?
Nadia A. is the Founder and CEO of APK Phageomics.
1 people are employed at APK Phageomics.